Surgical Technology
Perimembranous ventricular septal defect closure by Amplatzer occluder is safe enough for trials
Published in Medical Devices and Surgical Technology Week, March 19th, 2006
According to recent research from the United States, "This phase I study attempted to report the initial safety and efficacy results of transcatheter closure of perimembranous ventricular septal defects (PmVSDs) using the new Amplatzer Membranous VSD Occluder (AGA Medical Corp., Golden Valley, Minnesota) in the U.S. The most common congenital heart disease is PmVSD. Surgical repair is widely accepted, but still carries a small...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Devices and Surgical Technology Week
More Articles from Medical Devices and Surgical Technology Week
- Anesthesia
T-Line Tensymeter provides noninvasive surgical blood pressure monitoring - Cardiology
Cardiac arrest neurologic outcome improved by automated chest compression device - Medical Devices
Cochlear implant effects on peripheral vestibular system characterized - Neurology
Vertigo vestibular prosthesis prototype developed - Otorhinolaryngology
Laryngeal subglottal pressure assessment with incomplete airflow interruption feasible - Aesthetic Medicine
Despite risks, adults not shying away from cosmetic surgery and other treatments - More from this issue of Medical Devices and Surgical Technology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
